(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 2.88% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.3%.
Zimmer Biomet Holdings's revenue in 2026 is $8,570,400,000.On average, 28 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,643,291,509,504, with the lowest ZBH revenue forecast at $1,585,569,073,664, and the highest ZBH revenue forecast at $1,713,504,701,952. On average, 28 Wall Street analysts forecast ZBH's revenue for 2027 to be $1,701,960,214,784, with the lowest ZBH revenue forecast at $1,628,151,198,464, and the highest ZBH revenue forecast at $1,800,750,744,320.
In 2028, ZBH is forecast to generate $1,767,820,567,808 in revenue, with the lowest revenue forecast at $1,676,789,447,680 and the highest revenue forecast at $1,883,643,947,264.